Table 2.
Connection of CELSR3 expression with clinicopathological characteristics of PCa in the PRAD dataset.
| The PRAD dataset | |||
|---|---|---|---|
| CELSR3 expression | n | Mean ± SD | P |
| CELSR3 expression | |||
| Benign | - | ||
| PCa | 497 | -0.006±0.992 | - |
| Serum PSA | |||
| < 4 (ng/ml) | 413 | -0.057±0.796 | |
| ≥ 4 (ng/ml) | 27 | 0.550±2.415 | <0.002 |
| Age | |||
| < 66 years | 354 | 0.003±1.067 | |
| ≥ 66 years | 143 | -0.027±0.781 | 0.999 |
| Pathological stage | |||
| < T3A | 187 | -0.227±0.477 | |
| ≥ T3A | 303 | 0.099±0.984 | <0.001 |
| Gleason score | |||
| < 8 | 292 | -0.220±0.454 | |
| ≥8 | 205 | 0.299±1.394 | <0.001 |
| Overall survival | |||
| Alive | 487 | -0.035±0.836 | |
| Decease | 10 | 1.391±3.783 | <0.001 |
| Disease-free survival | |||
| Disease Free | 400 | -0.075±0.786 | |
| Recurred/Progressed | 91 | 0.173±1.033 | <0.05 |
- Lack of relative information or no results